Potential savings from biosimilars in Canada = Économies potentielles associées aux biosimilaires au Canada.: H82-34/2017-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.872231&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board. |
|---|---|
| Title | Potential savings from biosimilars in Canada = Économies potentielles associées aux biosimilaires au Canada. |
| Variant title | Économies potentielles associées aux biosimilaires au Canada |
| Publication type | Monograph |
| Language | Bilingual-[English | French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | "NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada." Issued also in HTML format. Includes bibliographical references. Text in English and in French. |
| Publishing information | [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2017] |
| Description | 1 online resource (1 page) : coloured graphs |
| Catalogue number |
|
| Subject terms | Prescription drugs |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: